TCR-T immunotherapy targeting EBV-associated malignancies

被引:0
|
作者
Jia, L. [1 ]
Chen, H. [1 ]
Liu, F. [1 ]
Wu, D. [2 ]
Ding, Z. [1 ]
Rui, W. [1 ]
Zhao, X. [1 ]
Chen, W. [2 ]
Lin, X. [1 ]
机构
[1] Tsinghua Univ, Beijing, Peoples R China
[2] Zhejiang Univ, Hangzhou, Zhejiang, Peoples R China
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P2286
引用
收藏
页码:1722 / 1722
页数:1
相关论文
共 50 条
  • [31] EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies
    Williams, Marshall V.
    Mena-Palomo, Irene
    Cox, Brandon
    Ariza, Maria Eugenia
    CANCERS, 2023, 15 (03)
  • [32] Targeting latent viral infection in EBV-associated lymphomas
    Kong, Isabella Y.
    Giulino-Roth, Lisa
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] Expression of PD-L1 in EBV-associated malignancies
    Li, Xiaoxu
    Zhang, Wenling
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [34] The Potential Effects of iTreg During Adoptive Immunotherapy With TCR-T Cell
    Zhang, Huan
    Li, Yi
    Liang, Zhaoduan
    CHEST, 2016, 149 (04) : 318A - 318A
  • [35] Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas
    Sarathkumara, Yomani D.
    Bibber, Nathan W. Van
    Liu, Zhiwei
    Heslop, Helen E.
    Rouce, Rayne H.
    Coghill, Anna E.
    Rooney, Cliona M.
    Proietti, Carla
    Doolan, Denise L.
    BLOOD ADVANCES, 2025, 9 (07) : 1658 - 1669
  • [36] TCR clonotype diversity is an age-associated marker for EBV-associated lymphoproliferative diseases or NK/T cell lymphoma
    Sun, Ting
    Cheng, Fei
    Huang, Ping
    Xuan, Zixue
    ASIAN JOURNAL OF SURGERY, 2024, 47 (12) : 5307 - 5309
  • [37] Adoptive transfer of polyclonal, EBV-specific cytotoxic T-cell lines for the prevention and treatment of EBV-associated malignancies
    Rooney, CM
    Huls, MH
    Rochester, RA
    Brenner, MK
    Heslop, HE
    CELL THERAPY, 2000, 5 : 45 - 60
  • [38] TCR-T新曙光
    李惠琳
    21世纪商业评论, 2020, (09) : 44 - 46
  • [39] The presence of defective Epstein-Barr virus (EBV) infection in EBV-associated hematological malignancies
    Okuno, Yusuke
    Murata, Takayuki
    Sato, Yoshitaka
    Ito, Yoshinori
    Yoshida, Kenichi
    Sawada, Akihisa
    Shiraishi, Yuichi
    Miyano, Satoru
    Takahashi, Yoshiyuki
    Kojima, Seiji
    Ogawa, Seishi
    Kimura, Hiroshi
    CANCER SCIENCE, 2018, 109 : 642 - 642
  • [40] Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
    Zhao, Qijie
    Jiang, Yu
    Xiang, Shixin
    Kaboli, Parham Jabbarzadeh
    Shen, Jing
    Zhao, Yueshui
    Wu, Xu
    Du, Fukuan
    Li, Mingxing
    Cho, Chi Hin
    Li, Jing
    Wen, Qinglian
    Liu, Tao
    Yi, Tao
    Xiao, Zhangang
    FRONTIERS IN IMMUNOLOGY, 2021, 12